Search Within

Patrick Glyn Morris

  1. "Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center "
Formats
  1. Journal Article (13)
  2. Meeting Abstract (13)
  3. Book Section (2)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (28)
  2. Department of Medicine (28)
  3. Solid Tumor Oncology Division (28)
  4. Breast Medicine Service (26)
  5. Survivorship Research (22)
  6. Epidemiology and Biostatistics (17)

More Groups

People
  1. Larry Norton (26)
  2. Clifford Hudis (22)
  3. Chau Dang (16)
  4. Sujata Patil (14)
  5. Alyson Merced (10)
  6. Heather Mcarthur (10)

More People

Years
  1. 2018 (1)
  2. 2016 (1)
  3. 2015 (1)
  4. 2013 (6)
  5. 2012 (5)
  6. 2011 (5)

More Years

Publications
  1. Journal of Clinical Oncology (9)
  2. Cancer Research (6)
  3. Cancer (2)
  4. Clinical Breast Cancer (2)
  5. Annals of Oncology (1)
  6. Cancer and the Heart. 2nd ed (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (9)
  2. American Association for Cancer Research (7)
  3. Elsevier Inc. (3)
  4. Wiley Blackwell (2)
  5. Cell Press (1)
  6. FEBS Press (1)

More Publishers

Results (28)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Use of adjuvant trastuzumab with chemotherapy in women with small, node-negative, HER2-positive breast cancers
    Meeting Abstract

    McArthur, H. L.; Mahoney, K.; Morris, P. G.; Patil, S.; Jacks, L. M.; Howard, J.; Norton, L.; Hudis, C.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Dasatinib (D) in combination with weekly (w) paclitaxel (P) for patients (pts) with metastatic breast carcinoma (MBC): A phase I/II study
    Meeting Abstract

    Fornier, M. N.; Morris, P. G.; Abbruzzi, A.; D'Andrea, G.; Gilewski, T.; Bromberg, J.; Dang, C. T.; Dickler, M. N.; Norton, L.; Hudis, C.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • A phase I-II trial of dasatinib (D) in combination with weekly (w) paclitaxel (P) for patients (Pts) with metastatic breast carcinoma (MBC)
    Meeting Abstract

    Morris, P. G.; Abbruzzi, A.; D'Andrea, G.; Gilewski, T.; Lake, D.; Bromberg, J.; Dang, C.; Dickler, M.; Modi, S.; Seidman, A. D.; more...
    Cancer Research (2010)

    Fulltext@MSK | Save
  • Dose-dense doxorubicin and cyclophosphamide followed by weekly paclitaxel with trastuzumab and lapatinib in HER2/neu-overexpressed/amplified breast cancer is not feasible because of excessive diarrhea
    Journal Article

    Dang, C.; Lin, N.; Moy, B.; Come, S.; Sugarman, S.; Morris, P.; Abbruzzi, A.; Chen, C.; Steingart, R.; Patil, S.; more...
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Dose-dense adjuvant doxorubicin and cyclophosphamide is not associated with frequent short-term changes in left ventricular ejection fraction
    Journal Article

    Morris, P. G.; Dickler, M.; Mcarthur, H. L.; Traina, T.; Sugarman, S.; Lin, N.; Moy, B.; Come, S.; Godfrey, L.; Nulsen, B.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Adjuvant dose-dense doxorubicin-cyclophosphamide x 4 with or without bevacizumab is safe: No evidence of short-term changes in left ventricular ejection fraction
    Meeting Abstract

    Morris, P. G.; Dickler, M.; Mcarthur, H.; Traina, T.; Godfrey, L.; Steingart, R.; Rugo, H.; Lin, N.; Moy, B.; Come, S.; more...
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Cardiac safety of adjuvant bevacizumab (B) plus dose-dense doxorubicin/cyclophosphamide (AC) followed by nanoparticle albumin-bound paclitaxel (nab-P) in patients with early stage breast cancer
    Meeting Abstract

    Mcarthur, H.; Rugo, H.; Nulsen, B.; Traina, T.; Patil, S.; Zhou, Q.; Steingart, R.; Dang, C.; Park, J.; Moasser, M.; more...
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Dose-dense (dd) doxorubicin-cyclophosphamide (AC) X 4 and short-term changes in left ventricular ejection fraction (LVEF) alone or with bevacizumab (B) in patients (pts) with early stage breast cancer (BC)
    Meeting Abstract

    Morris, P. G.; Dickler, M. N.; McArthur, H. L.; Traina, T. A.; Nulsen, B.; Steingart, R. M.; Rugo, S.; Norton, L.; Hudis, C. A.; Dang, C. T.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save